Adaptive clinical trial designs to detect interaction between treatment and a dichotomous biomarker
From MaRDI portal
Publication:2851584
DOI10.1002/CJS.11184zbMath1273.62256OpenAlexW1591775948MaRDI QIDQ2851584
Hongyu Zhao, Hongjian Zhu, Fei-fang Hu
Publication date: 11 October 2013
Published in: Canadian Journal of Statistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1002/cjs.11184
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)
Related Items (4)
Balancing Unobserved Covariates With Covariate-Adaptive Randomized Experiments ⋮ The impact of misclassification on covariate‐adaptive randomized clinical trials ⋮ New insights into adaptive enrichment designs ⋮ The impacts of unobserved covariates on covariate-adaptive randomized experiments
Cites Work
- Unnamed Item
- Asymptotic properties of covariate-adaptive randomization
- Efficient randomized-adaptive designs
- Handling covariates in the design of clinical trials
- Exact properties of Efron's biased coin randomization procedure
- The adaptive biased coin design for sequential experiments
- Asymptotic normality of urn models for clinical trials with delayed response
- Asymptotic properties of covariate-adjusted response-adaptive designs
- Adaptive designs for normal responses with prognostic factors
- Doubly adaptive biased coin designs with delayed responses
- Optimum biased coin designs for sequential clinical trials with prognostic factors
- An Application of an Urn Model to the Design of Sequential Controlled Clinical Trials
- On the Two Different Aspects of the Representative Method: The Method of Stratified Sampling and the Method of Purposive Selection
- The Theory of Response‐Adaptive Randomization in Clinical Trials
- Forcing a sequential experiment to be balanced
This page was built for publication: Adaptive clinical trial designs to detect interaction between treatment and a dichotomous biomarker
